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A BST R AC T   
 
Aim: To demonstrate the correlation between coronary collateral circulation (CCC) and atherogenic plasma 
index (AIP), one of the factors associated with the formation of collateral vessels. 
Methods: Hospital records of patients with chronic total occlusion (100% stenosis) in at least one coronary 
artery were evaluated. Triglycerides, HDL level, triglyceride/HDL ratio and atherogenic plasma index before 
coronary angiography were assessed for the 451 patients who met the study criteria.  
Results: Comparison of the two groups in terms of laboratory findings showed that triglyceride/HDL ratio 
(5.04±3.13 vs 3.56±2.12, p<0.001) and AIP (0.63±0.25 vs 0.48±0.25, p<0.001) were higher with statistical 
significance in the weak collateral group. The ROC analysis revealed an association between weak collateral 
formation and atherogenic plasma index with 64.7% sensitivity and 66.2% specificity using a cut-off value of 
0.58 for AIP. Accordingly, low AIP was found to be an independent predictor of good collateral artery 
formation.  
Conclusion: This study suggests that a high atherogenic plasma index may be an independent factor associated 
with poor collateral formation. 
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Introduction 
Atherosclerosis constitutes the base of coronary 
artery disease and is a progressive process with 
systemic involvement and is accompanied by 
inflammation [1]. Chronic total occlusion 
(CTO) of the coronary arteries is defined as the 
complete obstruction of the vessel lumen for at 
least three months. In the coronary angiography 
series, CTO was found in at least one coronary 
artery in approximately 1/3 of patients. 
Revascularisation of CTO lesions by 
percutaneous coronary intervention has 
positive impacts on the improvement of left 
ventricular function. Coronary collateral 
circulation (CCC), which exists in the normal 
heart, may be defined as vascular structures 
formed as a chronic, adaptive response between 
portions of the same coronary artery, or 
between different coronary arteries, to maintain 
the perfusion and viability of myocardial tissue 
distal to the lesion. This ensures blood flow to 
the ischemic myocardial tissue when critical 
stenosis or total occlusion disrupts blood flow 
[2]. Although it was initially accepted that all 
coronary collateral vessels develop when 
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needed, it is currently believed that coronary 
collateral vascular development occurs both by 
the formation of new vascular structures 
(angiogenesis) with the budding of capillaries 
from existing vascular structures, and by the 
development of arteriogenesis, which results 
from the growth and development of 
anastomotic channels present between the 
coronary arteries. These two mechanisms occur 
parallel to each other. When there are 
cardiovascular risk factors, such as 
hypercholesterolemia, advanced age, 
hypertension, diabetes, genetic predisposition, 
obesity and smoking, the release of angiogenic 
factors decreases [3]. Therefore, it is considered 
that the development of CCC is also adversely 
affected. Collateral arteries often become 
visible angiographically in cases where more 
than 90% of the main coronary artery diameter 
is occluded. Different methods have been used 
to show and group CCC angiographically. 
Rentrop classification classified the collateral 
area by the filling of the vascular structure, 
while Gibson and Werner classified the area by 
the size of the collateral vessel. The mechanism 
of development of coronary collateral 
circulation is still unclear, and clinical studies 
on this subject are ongoing. There is a 
relationship between factors such as 
hypertension, age, diabetes mellitus, 
hyperlipidemia, obesity and systemic 
inflammatory events, which have impacts on 
the development of coronary collateral and the 
inflammatory response caused by lipid 
parameters in metabolic syndrome and 
ischemic heart disease. Past studies have shown 
that vascular endothelial cells are an important 
factor in the development and progression of 
CCC [4,5]. Myocardial hypoxia may facilitate 
the development of coronary collateral vessels. 
Patients with chronic obstructive pulmonary 
disease (COPD) have chronic hypoxemia. 
Ramazan Topsakal et al. showed that the 
development of coronary collateral vessels in 
98 COPD patients was better in patients with 
COPD than in patients without COPD [6]. Jan-
Erik Guelker et al. showed that the triglyceride 
(TG)/high-density lipoprotein (HDL) ratio can 
be an independent factor for complex CTO 
lesions [7]. The logarithm of the molar ratio of 
TG to high-density lipoprotein cholesterol 
(HDL-C) levels, the atherogenic index of 
plasma (AIP), is closely related and inversely 
proportional to the diameter of low-density 
lipoprotein cholesterol (LDL-C) particles, 
which indirectly reflects small dense low-
density lipoprotein (sdLDL) levels [8]. This 
value has been established as an index for 
predicting plasma atherosclerosis and CAD 
[9,10]. Our study was aimed at investigating the 
effect of AIP obtained by the logarithmic 
transformation of the TG/HDL ratio on the 
development of coronary collateral, regardless 
of other factors, and to determine the 
relationship between them in patients in whom 
CCC was found. 
 
Materials and methods 
Study population 
Our study was approved by the Ethics 
Committee of Dicle University Faculty of 
Medicine on 21.01.2019 with file number 43. 
Later in our study, the data of the patients were 
retrospectively reviewed in the coronary 
angiography series performed between 
03/2014-11/2018 at the Department of 
Cardiology of the Heart Hospital of Dicle 
University Faculty of Medicine. The inclusion 
criteria of the study will basically be based on 
the criterion of having lesion or lesions assessed 
as chronic total occlusion (100% stenosis) in at 
least one or more coronary arteries in the 
coronary angiography. Patients were selected 
consecutively. The exclusion criteria of the 
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study include admission to the hospital as 
myocardial infarction with ST-segment 
elevation, a history of previous coronary artery 
bypass, using a statin, being under the age of 18 
years, using nonsteroidal or steroid, a history of 
chronic rheumatological disease, presence of 
hematological malignancy or any other history 
of malignancy. 
Blood samples and echocardiography 
Blood samples were collected from anterior 
forearm in all patients included in the study in 
the supine position after hospitalization in our 
cardiology clinic. Measurements of lipid levels 
were performed in serum separated by 
centrifuge at 3000 rpm at room temperature. 
Total cholesterol (TC), triglyceride (TG), high-
density cholesterol (HDL) were assessed by 
Konelab kits and Konnelab 60i and Thermo 
Clinical Labsystems devices (Thermo Clinical 
Labsystems Oy Ratostic 2, Vantae, Finland). 
The LDL cholesterol level was calculated using 
the Friedewald formula in patients. Left 
ventricular ejection fractions were measured by 
transthoracic two-dimensional 
echocardiography in the echocardiography 
laboratory during the admission to the 
Department of Cardiology (Vivid S6, GE 
Medical Systems, USA).  
Coronary angiography 
Selective coronary angiography was performed 
by the Judkins technique, using 6F or 7F 
catheters using the right or left femoral or radial 
approach in patients. Coronary angiography 
images were assessed by two experienced 
cardiologists blinded to the laboratory values 
and clinical characteristics of the patients. The 
degree of obstruction in the coronary arteries 
was decided based on the projection with the 
greatest stenosis. Collateral development was 
assessed according to the Rentrop grading. In 
the evaluation made according to the Rentrop 
grading; Rentrop 0: No collateral filling, 
Rentrop 1: Barely detectable collateral flow and 
no filling of epicardial arteries, Rentrop 2: 
Partial filling, contrast medium enters but fails 
to completely opacify the epicardial arteries, 
Rentrop 3: Complete perfusion, contrast 
medium completely opacifies the epicardial 
arteries. Rentrop 0 and 1 were evaluated as 
poorly developed collateral circulation, while 
Rentrop 2 and 3 were considered to be well-
developed collateral circulation. 
Measurement of atherogenic index of plasma 
(AIP) 
Triglyceride and HDL values were measured 
from the blood samples collected before the 
coronary angiography of the patients in the 
study and were recorded in mg/dL. The 
atherogenic index of plasma (AIP) was 
calculated as the logarithmic transformation of 
the triglyceride/HDL ratio. AIP of <0.11 was 
considered low risk, AIP of 0.11-0.21 moderate 
risk, AIP of > 0.21 increased risk [8,11].  
Statistical analysis 
All analyzes were performed with SPSS 
version 25.0 (SPSS Inc., Chicago, Illinois, 
USA). Whether the distribution of continuous 
variables is normal was determined by 
Kolmogorov-Smirnov and Shapiro-Wilk tests. 
Descriptive statistics were expressed as mean ± 
standard deviation for continuous variables, 
and as the number of cases and (%) for the 
nominal variables. Continuous variables with 
normal distribution were compared using the 
Student t-test, and continuous variables with 
non-normal distribution were compared using 
the Mann Whitney-U test. Chi-square test and 
Fisher’s Exact test were used to compare 
categorical variables. Pearson's correlation test 
was used to evaluate the relationship between 
normally distributed parameters and 
Spearman's rho correlation test was used to 
examine the relationship between parameters 
that are not normally distributed. In the Pearson 
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correlation analysis, the correlation coefficient 
(r) was calculated. Those with a correlation 
coefficient between 0 and 0.25 were defined as 
very weakly correlated, those with a correlation 
coefficient between 0.25 and 0.50 as weakly 
correlated, those with a correlation coefficient 
between 0.50 and 0.69 as moderately 
correlated, those with a correlation coefficient 
between 0.70 and 0.89 as strongly correlated, 
and those with a correlation coefficient between 
0.90 and 1 as very strongly correlated. 
Also, the significance tests of the correlations 
were performed and p-values, also known as the 
degree of significance, were given. The 
statistical significance level of the obtained data 
was interpreted with the “p” value. p values of 

























Multivariate logistic regression analysis was 
used to evaluate independent determinants 
influencing collateral development. All 
significant variables were included in the 
logistic regression model, and the results were 
obtained in the 95% confidence interval and 
expressed as odds ratio (OR). 
In addition, ROC analysis and curves (Receiver 
Operating Characteristics Curve) were used to 
determine the diagnostic performance and 
cutoff values of the TG/HDL ratio and the 
Atherogenic index of plasma (AIP). 
 
Results  
A total of 451 patients, 126 women (27.9%) and 
325 men (72.1%), aged between 33 and 92 


























Table 1. Demographic and clinical characteristics of the patients. 







Age 60.70±10.85 62.86±11.40 0.039 
Gender, (N, %) 
Female 69 (29.7%) 57 (26.0%) 
0.380 
Male 163 (70.3%) 162 (74.0%) 
HT, S (N, %)   98 (42.2%) 77 (35.2%) 0.123 
DM, S (N, %) 105 (45.3%) 55 (25.1%) 0.000 
Smoking, S (N, %) 127 (54.7%) 57(26.0%) 0.000 
Family history, S (N, %) 28 (12.1%) 15 (6.8%) 0.059 
Previous MI, S (N, %) 57 (24.6%) 49 (22.4%) 0.583 
Beta-blocker, S (N, %) 74 (31.9%) 59 (26.9%) 0.249 
ACE-I/ARB, S (N, %) 94 (40.5%) 76 (34.7%) 0.203 
CCB, S (N, %) 47 (20.3%) 33 (15.1%) 0.143 
Nitrate, S (N, %) 21 (9.1%) 18 (8.2%) 0.753 
ASA, S (N, %) 39 (16.8%) 40 (18.3%) 0.685 
Clopidogrel, S (N, %) 10 (4.3%) 5 (2.3%) 0.230 
HT: Hypertension, DM: diabetes mellitus, MI: myocardial infarction, ACE-I/ARB: Angiotensin-converting 
enzyme inhibitor/ Angiotensin receptor blockers, CCB: calcium channel blocker, ASA: acetylsalicylic acid.  
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years, were included in our study. The mean age 
of the patients was found to be 60.21 ± 10.83 
years in men and 65.72 ± 11.05 years in women.  
219 patients (48.6%) with Rentrop grade 2 and 
3 collaterals angiographically constituted the 
good collateral group and 232 patients (51.4%) 
with grade 0 and 1 collateral the poor collateral 
group. Those with good collaterals and those 
with poor collaterals were compared regarding 
gender, age, diabetes mellitus (DM), 
hypertension (HT), smoking, family history, 
previous myocardial infarction (Pre. MI), use of 
Angiotensin-converting enzyme inhibitor 
(ACE-I), Angiotensin receptor blockers (ARB), 
acetylsalicylic acid (ASA), clopidogrel, 
calcium channel blocker (CCB), nitrate, and 
beta-blocker (Table 1).  
Considering the previous histories of the 
patients, 105 (45.3%) patients of the poor 
collateral group and 55 (25.1%) patients of the 
good collateral group had a history of DM. 
When both groups were compared, there was a 
statistically significant difference (p<0.001). 
127 (54.7%) patients in the poor collateral 
group and 57 (26.0%) patients in the good 
collateral group had a history of smoking. 
Statistically significant difference was found 
between the two groups (p<0.001).  
Angiographic findings of patients according to 
collateral grade after coronary angiography are 
shown in (Table 2). Comparing the arteries 
developing poor collaterals angiographically, 
while chronic total occlusion (CTO≥2 vessels) 
was found in the LAD in 36%, in the CX in 
22.8%, in the RCA in 56%, and in multiple 
vessels in 14%, chronic total occlusion was 
found in 32% in the LAD, in 22% in the CX, in 
63% in the RCA, in 14% in multiple vessels in 
the good collateral group. However, there was 
no statistically significant difference between 
the two groups (p>0.05). Comparing all three 
















detected in the RCA. This result was consistent 
with previous large-scale studies. Comparing 
the poor collateral group and the good collateral 
group in terms of CTOs in the RCA, although 
good collaterals were seen more, there was no 
statistically significant difference (p=0.133). 
Although high-density lipoprotein (HDL) level 
was higher in the good collateral group, there 
was no statistically significant difference 
(p=0.397). Fasting glucose level, triglyceride 
level, and total cholesterol level were 
significantly higher in the poor collateral group 
(p<0.001, p<0.001, p=0.019, respectively). 
The sodium level was significantly higher in the 
good collateral group, incidentally (p=0.009) 
(Table 3). 
When two groups were compared in terms of 
echocardiographic findings, the mean left 
ventricular ejection fraction (EF) at admission 
was 48.05 ± 7.96 in the poor collateral group 
and 51.24 ± 9.77 in the good collateral group 
and there was a statistically significant 
difference between the two groups (p<0.001) 
(Table 3). 
When two groups were compared regarding the 
triglyceride/HDL ratio (TGHDL), it was found 
to be 5.04 ± 3.13  in  the  poor  collateral  group  











LAD 84 (36%) 71 (32%) 0.397 
Cx 53 (23%) 47 (22%) 0.724 
RCA 129 (56%) 137 (63%) 0.133 
CTO≥2 vessels 32 (14%) 30 (14%) 0.977 
 
LAD: Left anterior descending artery, Cx: 
Circumflex artery, RCA: Right coronary artery, 
CTO: Chronic total occlusion. 
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and 3.56 ± 2.12 in the good collateral group on 
average. It was statistically significantly higher 
in the poor collateral group (p<0.001) (Table 
3). When two groups were compared 






































(AIP), it was found to be 0.63 ± 0.25 in the poor 
collateral group, and 0.48 ± 0.25 in the good 
collateral group on average. It was statistically 
significantly higher in the poor collateral group 
(p<0.001) (Table 3). 








WBC (x10³ µL) 9.40±2.50 9.13±2.56 0.262 
RBC (x106 µL)  4.96±0.62 4.96±0.80 0.976 
HGB  (g/dL) 13.84±2.05 13.82±2.18 0.956 
HCT  42.66±5.25 42.44±5.75 0.676 
MCV (x10³ µL) 86.20±6.24 86.41±5.94 0.722 
RDW  12.22±1.96 12.20±1.87 0.952 
Glucose (mg/dL) 158.5±75.60 132.3±55.23 0.000 
Urea (mg/dL) 40.97±22.50 42.75±23.23 0.410 
Kreatinin  (mg/dL) 1.03±0.74 1.09±0.89 0.424 
Total Protein (gr/dL) 7.24±0.82 7.87±0.65 0.328 
Albumin (gr/dL) 3.71±0.42 3.65±0.42 0.140 
Total Bilirubin (mg/dL) 0.65±0.35 0.66±0.33 0.933 
ALT (U/L) 24.96±19.55 25.19±20.93 0.906 
AST (U/L) 27.50±1.44 30.04±2.05 0.313 
ALP (U/L) 82.09±28.49 86.23±31.36 0.175 
GGT (U/L) 37.74±2.63 41.91±4.30 0.411 
LDH (U/L) 264.6±116.6 274.1±124.4 0.403 
Triglyceride (mg/dL) 186.7±86.75 143.9±69.16 0.000 
Total Cholesterol (mg/dL) 183.9±47.95 173.4±46.63 0.019 
HDL (mg/dL) 41.77±26.73 43.38±8.71 0.397 
LDL ( mg/dL) 102.1±39.12 102.4±38.41 0.935 
Calcium (mg/dL) 9.19±0.72 9.16±0.55 0.553 
Sodium (mmol/L) 136.6±2.73 137.3±2.94 0.009 
Potassium (mmol/L) 4.47±0.41 4.44±0.45 0.527 
CRP (mg/dL) 0.95±0.12 1.35±0.24 0.151 
TSH (IU/mL) 1.42±0.15 1.96±0.58 0.401 
T3 (pg/mL) 4.98±2.88 4.65±1.27 0.339 
T4 (ng/L) 17.68±5.44 16.99±3.42 0.318 
TGHDL 5.04±3.13 3.56±2.12 0.000 
AIP 0.63±0.25 0.48±0.25 0.000 
EF (%) 48.05±7.96 51.24±9.77 0.000 
 
ALT: Alanine transaminase, AST: Aspartate transaminase, ALP: Alkalen fosfataz, GGT: Gama glutamil 
transpeptidaz, LDH: Laktat dehidrogenaz, HDL: High-density cholesterol. LDL: Low density lipoprotein, 
CRP: C-reactive protein, TSH: Thyroid-stimulating hormone, TGHDL: High triglyceride high-density 
lipoprotein cholesterol ratio, AIP: Atherogenic index of plasma, EF: Ejection fraction. 
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When correlation analysis was performed 
between collateral grade and the TG/HDL ratio 
(TGHDL) (rs = -0.299, p <0.001) and between 
collateral grade and the atherogenic index of 
plasma (rs = -0.299, p <0.001), there was a 
weak negative correlation which was 
statistically significant (rs: Spearman's rho 










In the multivariate logistic regression analysis 
performed to find the factors affecting collateral 
development, the TG/HDL ratio (TGHDL) and 
the atherogenic index of plasma (AIP) were 
found to be statistically significant, 
independently of other factors. Accordingly, 
low TG/HDL ratio (TGHDL) and AIP were 
found to be independent predictors of the 
development of the good collateral arteries 












In the ROC analysis of the data, the 
development of collateral was compared with 
the TG/HDL ratio (TGHDL) and the 
atherogenic index of plasma (AIP). There was 
a statistically significant negative correlation 
between collateral development and the 
TG/HDL ratio (TGHDL) and the atherogenic 
index of plasma (AIP). When the cutoff value 
was considered 3.81 for the TG/HDL ratio and 
0.58 for the atherogenic index of plasma (AIP), 
the increase in the TG/HDL ratio and the 
atherogenic index of plasma was found to be 
associated with the presence of poor collaterals 
with a sensitivity of 64.7% and specificity of 
66.2% (Table 6, Figure 1). 
 
Discussion 
The factor affecting coronary collateral 
development is an inflammatory response. One 
of the factors that started this inflammatory 
process is AIP. When starting our study, we 
aimed to investigate the predictability of a 
decrease in collateral development when there 
is an increase in AIP and the relationship 
between them. In order to reveal this 
relationship, patients were selected from the 
groups that showed homogenous distribution in 
terms of factors other than AIP, which we think 
is particularly effective on collateral 
development. Since we aimed to investigate the 
effect of AIP on CCC in patients with coronary 
artery disease, we did not include patients 
taking lipid-lowering drugs in our study. 
Therefore, in our study, the possible effects of 
drugs with the ability to reduce lipid levels on 
HDL cholesterol, CCC and triglyceride levels 
were not mentioned. In our study, the left 
ventricular systolic functions were statistically 
significantly higher in the good collateral 
group, and a statistically significant correlation 
was found between AIP, diabetes mellitus, 
smoking and collateral development. In a study 
conducted by Abaci et al. on 205 diabetes 
mellitus (DM) patients, it was shown that 
collateral vessel development in DM was worse 
than in non-diabetic patients. We can say that  
Table 4. Correlation analysis between collateral 
grade and the TG/HDL ratio (TGHDL) and the 
atherogenic index of plasma (AIP). 
 
Parameter rs p 
TG/HDL -0.299 0.000 
AIP -0.299 0.000 
 
Table 5. Multivariate Logistic Regression Analysis 
between collateral development and the TG/HDL 
Ratio (TGHDL) and the atherogenic index of 
plasma (AIP). 
 
Parameter OR 95% CI p 
Age 1.008 0.987-1.029 0.470 
Gender 0.631 0.383-1.038 0.070 
TG/HDL 0.819 0.741-0.905 0.000 
AIP 0.083 0.035-0.196 0.000 
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DM is an important factor among the factors 
affecting the development of coronary 
collateral [12]. 
For visible collateral vessels, there must be total 
or subtotal occlusion of the coronary arteries 
[13]. Therefore, we included patients with at 
least one total occluded coronary artery in our 
study. Also, collateral development is a time-
dependent continuity. The development of 
coronary collaterals was demonstrated in the 
first six hours following acute myocardial 
infarction, and all collaterals developed were 
found to become visible in the coronary 
angiography performed within 24 hours after 
myocardial infarction. To make an accurate 
assessment of CCC, we did not include patients 
who underwent coronary angiography in the 
first 24 hours after acute coronary syndrome. 
An experimental study showed that HDL-C 
increases coronary artery blood flow through 
NO-mediated vasodilation [14]. This finding 
shows that HDL cholesterol can positively 
affect collateral development with the increased 
effect of NO. Rossi et al. have shown that HDL 
cholesterol is a powerful indicator of the 
number and function of circulating endothelial 
progenitor cells (EPCs), which also repair the 
endothelial layer [15]. Spieker et al. showed 
that HDL cholesterol is an endothelial 
protective factor in a hypercholesterolemic man 





























disease [16]. In healthy individuals without an 
additional risk factor for cardiovascular 
disease, low HDL-C has been shown to be an 
independent risk factor for endothelial 
dysfunction [17]. 
The results obtained from these studies clearly 
prove that HDL-C has endothelial layer 
protection and anti-inflammatory effects. 
Therefore, patients with weak CCC may have 
low HDL cholesterol levels. This can be 
explained by the anti-inflammatory and 
endothelial protective properties of HDL-C. 
However, in our study, although HDL 
cholesterol levels were found to be higher in the 
Table 6: ROC analysis. 
 
Area Under the Curve [AUC] 
 AUC p value 95% Confidence 
interval (CI) 
Cut off value Sensitivity Specificity 
Lower-Upper Limit 
TG/HDL 673 0.00 623-722 3.81 64.7% 66.2% 
AIP 673 0.00 623-722 0.58 64.7% 66.2% 
 
 
Figure 1: ROC analysis comparison of the 
relationship between collateral development and the 
atherogenic index of plasma and the TG/HDL Ratio. 
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group developing good collaterals, no 
statistically significant difference was found (p 
= 0.397).  
First described by Dobiášová and Frohlich in 
2001, AIP [18] is a comprehensive lipid index 
and a powerful marker for predicting CAD risk 
[19]. While Niroumand et al. suggested that 
AIP could be used as a regular monitoring index 
of CAD in daily practice [20], Wan et al. proved 
an elevated AIP to be a strong independent 
predictor of all-cause mortality and 
cardiovascular disease after coronary 
revascularization [21]. However, several recent 
studies have proven AIP to be of significant 
value in assessing the severity of coronary 
syndrome. Another study showed a significant 
relationship between AIP and the progression 
of coronary artery calcification [22]. 
Furthermore, in a 7–8-year follow-up study of 
2,676 middle-aged adults, AIP was confirmed 
to be a prognostic marker for predicting CAD-
related morbidity [23]. AIP is independently 
associated with the occurrence of CTO and is 
thought to predict the presence of CTO and 
disease severity [24].  
Nevertheless, a higher AIP may be considered 
an inflammatory marker that mediates 
endothelial function and the growth of 
collateral circulation by affecting a number of 
inflammatory reactions. Strong evidence in the 
prediction of the increase in AIP reducing 
coronary collateral development has provided 
important data: AIP is a determinant via local 
inflammatory response. 
Our study has some limitations. First, the 
sample size was relatively small, a multi-center 
study should be designed to present the result as 
strong evidence. Secondly, the bias was 
inevitable as the subjects included as a case-
control study were enrolled from a single 
center. Thirdly, as this study was performed 
cross-sectionally, not knowing clearly whether 
the blood sample was collected after proper diet 
preparation and the condition of other daily 
events affecting the atherogenic index of 
plasma related to TG/HDL ratio made it 
difficult to comment on its relationship with the 
development of CCC. Fourthly, as HDL 
cholesterol dysfunction may also occur, serum 
HDL cholesterol level does not fully 
demonstrate the function of HDL cholesterol. 
Fifthly, it is unknown whether the results of our 
study can be extended to other populations. 
Conclusion 
We demonstrated that a high atherogenic 
plasma index is an independent factor 
associated with weak collateral formation. The 
atherogenic index of plasma, which is simple, 
non-invasive, and economic, obtains a fast 
result and has an important value, should be 
carefully evaluated in determining individuals 
at risk for cardiovascular diseases, especially in 
individuals with a family history of coronary 
heart diseases. The development of 
cardiovascular diseases may be decreased by 
reducing the atherogenic index of plasma.  
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